{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:51Z","timestamp":1791216591386,"version":"4.1.0"},"reference-count":107,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T00:00:00Z","timestamp":1623283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01DA048879"],"award-info":[{"award-number":["1R01DA048879"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Among the myriad of cellular and molecular processes identified as contributing to pathological pain, disinhibition of spinal cord nociceptive signaling to higher cortical centers plays a critical role. Importantly, evidence suggests that impaired glycinergic neurotransmission develops in the dorsal horn of the spinal cord in inflammatory and neuropathic pain models and is a key maladaptive mechanism causing mechanical hyperalgesia and allodynia. Thus, it has been hypothesized that pharmacological agents capable of augmenting glycinergic tone within the dorsal horn may be able to blunt or block aberrant nociceptor signaling to the brain and serve as a novel class of analgesics for various pathological pain states. Indeed, drugs that enhance dysfunctional glycinergic transmission, and in particular inhibitors of the glycine transporters (GlyT1 and GlyT2), are generating widespread interest as a potential class of novel analgesics. The GlyTs are Na+\/Cl\u2212-dependent transporters of the solute carrier 6 (SLC6) family and it has been proposed that the inhibition of them presents a possible mechanism by which to increase spinal extracellular glycine concentrations and enhance GlyR-mediated inhibitory neurotransmission in the dorsal horn. Various inhibitors of both GlyT1 and GlyT2 have demonstrated broad analgesic efficacy in several preclinical models of acute and chronic pain, providing promise for the approach to deliver a first-in-class non-opioid analgesic with a mechanism of action differentiated from current standard of care. This review will highlight the therapeutic potential of GlyT inhibitors as a novel class of analgesics, present recent advances reported for the field, and discuss the key challenges associated with the development of a GlyT inhibitor into a safe and effective agent to treat pain.<\/jats:p>","DOI":"10.3390\/biom11060864","type":"journal-article","created":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T13:31:39Z","timestamp":1623331899000},"page":"864","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Inhibition of Glycine Re-Uptake: A Potential Approach for Treating Pain by Augmenting Glycine-Mediated Spinal Neurotransmission and Blunting Central Nociceptive Signaling"],"prefix":"10.3390","volume":"11","author":[{"given":"Christopher L.","family":"Cioffi","sequence":"first","affiliation":[{"name":"Departments of Basic and Clinical Sciences and Pharmaceutical Sciences, Albany College of Pharmacy and Health Sciences, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: A review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.aaf8933","article-title":"Neural circuits for pain: Recent advances and current views","volume":"354","author":"Peirs","year":"2016","journal-title":"Science"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13295-011-0018-1","article-title":"Spinal neuroplasticity in chronic pain","volume":"2","author":"Zeilhofer","year":"2011","journal-title":"e-Neuroforum"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s11916-009-0035-8","article-title":"Spinal inhibitory neurotransmission in neuropathic pain","volume":"13","author":"Taylor","year":"2009","journal-title":"Curr. Pain Headache Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/physrev.00043.2010","article-title":"Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control","volume":"92","author":"Zeilhofer","year":"2012","journal-title":"Physiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-3-662-46450-2_9","article-title":"Plasticity of Inhibition in the Spinal Cord","volume":"Volume 227","author":"Todd","year":"2015","journal-title":"Pain Control. Handbook of Experimental Pharmacology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic phenotype to reveal neural mechanisms","volume":"73","author":"Baron","year":"2012","journal-title":"Neuron"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.neuroscience.2015.05.020","article-title":"Circuitry and plasticity of the dorsal horn\u2014Toward a better understanding of neuropathic pain","volume":"300","author":"West","year":"2015","journal-title":"Neuroscience"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev-pharmtox-010611-134636","article-title":"Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control","volume":"52","author":"Zeilhofer","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1523\/JNEUROSCI.4584-05.2006","article-title":"Disinhibition opens the gate to pathological pain signaling in superficial neurokinin 1 receptor-expressing neurons in the rat spinal cord","volume":"26","author":"Torsney","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Miraucourt, L.S., Dallel, R., and Voisin, D.L. (2007). Glycine Inhibitory Dysfunction Turns Touch into Pain through PKCgamma Interneurons. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001116"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1172\/JCI70026","article-title":"A feed-forward spinal cord glycinergic neural circuit gates mechanical allodynia","volume":"123","author":"Lu","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00018-005-5107-2","article-title":"The glycinergic control of spinal pain processing","volume":"62","author":"Zeilhofer","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2009.03.018","article-title":"Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain","volume":"123","author":"Dohi","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nrd3893","article-title":"Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain","volume":"12","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1021\/acs.jmedchem.7b00956","article-title":"Modulation of Glycine-Mediated Spinal Neurotransmission for the Treatment of Chronic Pain","volume":"61","author":"Cioffi","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2014.05.006","article-title":"Glycine transport inhibitors for the treatment of pain","volume":"35","author":"Vandenberg","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuint.2015.12.007","article-title":"Glycine transporter2 inhibitors: Getting the balance right","volume":"98","author":"Vandenberg","year":"2016","journal-title":"Neurochem. Int."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrn2947","article-title":"Neuronal circuitry for pain processing in the dorsal horn","volume":"11","author":"Todd","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.neuro.051508.135531","article-title":"Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage","volume":"32","author":"Costigan","year":"2009","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.neuron.2015.02.028","article-title":"Targeted Ablation, Silencing, and Activation Establish Glycinergic Dorsal Horn Neurons as Key Components of a Spinal Gate for Pain and Itch","volume":"85","author":"Foster","year":"2015","journal-title":"Neuron"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0024-3205(85)90523-5","article-title":"Hyperalgesia induced by altered glycinergic activity at the spinal cord","volume":"37","author":"Beyer","year":"1985","journal-title":"Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jn.1997.78.2.628","article-title":"Spinal Strychnine Alters Response Properties of Nociceptive-Specific Neurons in Rat Medial Thalamus","volume":"78","author":"Sherman","year":"1997","journal-title":"J. Neurophysiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(94)90146-5","article-title":"Morphine insensitive allodynia is produced by intrathecal strychnine in the lightly anesthetized rat","volume":"56","author":"Sherman","year":"1994","journal-title":"Pain"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Imlach, W.L., Bhola, R.F., Mohammadi, S.A., and Christie, M. (2016). Glycinergic dysfunction in a subpopulation of dorsal horn interneurons in a rat model of neuropathic pain. Sci. Rep., 6.","DOI":"10.1038\/srep37104"},{"key":"ref_27","first-page":"938","article-title":"Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain","volume":"424","author":"Coull","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/01616412.1998.11740500","article-title":"Glycine receptor reduction within segmental gray matter in a rat model of neuropathic pain","volume":"20","author":"Simpson","year":"1998","journal-title":"Neurol. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1126\/science.1094925","article-title":"GlyR alpha3: An essential target for spinal PGE2-mediated inflammatory pain sensitization","volume":"304","author":"Harvey","year":"2004","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neulet.2015.10.072","article-title":"Reduction of spinal glycine receptor-mediated miniature inhibitory postsynaptic currents in streptozotocin-induced diabetic neuropathic pain","volume":"611","author":"Chiu","year":"2016","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-4886(03)00175-4","article-title":"Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats","volume":"183","author":"Miyazato","year":"2003","journal-title":"Exp. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/BF02532399","article-title":"Reduction in the mechanonociceptive response by intrathecal administration of glycine and related compounds","volume":"21","author":"Simpson","year":"1996","journal-title":"Neurochem. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1023\/A:1027333506020","article-title":"Reduction in Thermal Hyperalgesia by Intrathecal Administration of Glycine and Related Compounds","volume":"22","author":"Simpson","year":"1997","journal-title":"Neurochem. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4097\/kjae.2010.58.1.76","article-title":"Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice","volume":"58","author":"Lim","year":"2010","journal-title":"Korean J. Anesthesiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","article-title":"Glycine transporters: Essential regulators of neurotransmission","volume":"30","author":"Eulenburg","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","article-title":"Glycine transporters are differentially expressed among CNS cells","volume":"15","author":"Zafra","year":"1995","journal-title":"J. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.tips.2006.05.003","article-title":"Neurotransmitter transporters: Molecular function of important drug targets","volume":"27","author":"Gether","year":"2006","journal-title":"Trend Pharm. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/0896-6273(93)90201-2","article-title":"Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene","volume":"10","author":"Borowsky","year":"1993","journal-title":"Neuron"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0896-6273(00)80901-0","article-title":"Neuronal and glial glycine transporters have different stoichiometries","volume":"25","author":"Roux","year":"2000","journal-title":"Neuron"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1460-9568.1995.tb01125.x","article-title":"Regional Distribution and Developmental Variation of the Glycine Transporters GLYT1 and GLYT2 in the Rat CNS","volume":"7","author":"Zafra","year":"1995","journal-title":"Eur. J. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neulet.2015.06.026","article-title":"Glycine transporter GlyT1, but not GlyT2, is expressed in rat dorsal root ganglion\u2014Possible implications for neuropathic pain","volume":"600","author":"Barthel","year":"2015","journal-title":"Neurosci. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.exphem.2016.07.003","article-title":"Effects of GlyT1 inhibition on erythropoiesis and iron homeostasis in rats","volume":"44","author":"Winter","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/cercor\/bhh147","article-title":"Localization of the GLYT1 Glycine Transporter at Glutamatergic Synapses in the Rat Brain","volume":"15","author":"Cubelos","year":"2005","journal-title":"Cereb. Cortex"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0896-6273(03)00672-X","article-title":"Inactivation of the Glycine Transporter 1 Gene Discloses Vital Role of Glial Glycine Uptake in Glycinergic Inhibition","volume":"40","author":"Gomeza","year":"2003","journal-title":"Neuron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1471-4159.2010.06802.x","article-title":"Functional \u2018glial\u2019 GLYT1 glycine transporters expressed in neurons","volume":"114","author":"Raiteri","year":"2010","journal-title":"J. Neurochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"15730","DOI":"10.1073\/pnas.95.26.15730","article-title":"Modulation of N-methyl-d-aspartate receptor function by glycine transport","volume":"95","author":"Bergeron","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/ALN.0000000000000203","article-title":"Long-term Application of Glycine Transporter Inhibitors Acts Antineuropathic and Modulates Spinal N-methyl-d-aspartate Receptor Subunit NR-1 Expression in Rats","volume":"121","author":"Barthel","year":"2014","journal-title":"Anesthesiology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1523\/JNEUROSCI.1024-07.2007","article-title":"The Transporters GlyT2 and VIAAT Cooperate to Determine the Vesicular Glycinergic Phenotype","volume":"27","author":"Aubrey","year":"2007","journal-title":"J. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1471-4159.1995.64031026.x","article-title":"Localization of Glycine Neurotransmitter Transporter (GLYT2) Reveals Correlation with the Distribution of Glycine Receptor","volume":"64","author":"Jursky","year":"2002","journal-title":"J. Neurochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1523\/JNEUROSCI.0509-08.2008","article-title":"The Glycine Transporter GlyT2 Controls the Dynamics of Synaptic Vesicle Refilling in Inhibitory Spinal Cord Neurons","volume":"28","author":"Rousseau","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0028-3908(01)00043-0","article-title":"Pharmacological assessment of the role of the glycine transporter GlyT-1 in mediating high-affinity glycine uptake by rat cerebral cortex and cerebellum synaptosomes","volume":"41","author":"Herdon","year":"2001","journal-title":"Neuropharmacology"},{"key":"ref_52","unstructured":"Walker, G.B., Ge, J., Cruise, L., Hamilton, W., Bruin, J., Henry, B., and Hill, D.R. (2007). Characterization of Org 25935: A selective GlyT-1 glycine uptake inhibitor. Schizophr. Bull., 33."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0028-3908(03)00227-2","article-title":"Pharmacology and expression analysis of glycine transporter GlyT1 with [3H]-(N-[3-(4\u2032-fluorophenyl)-3-(4\u2032phenylphenoxy)propyl])sarcosine","volume":"45","author":"Mallorga","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1021\/jm100210p","article-title":"Selective GlyT1 inhibitors: Discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]-[5-methylsulfonyl-2-((S)-2,2,2-trifluoromethylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia","volume":"53","author":"Pinard","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/j.pain.0000000000000206","article-title":"The lidocaine metabolite N-ethylglycine has antinociceptive effects in experimental inflammatory and neuropathic pain","volume":"156","author":"Werdehausen","year":"2015","journal-title":"Pain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01497","article-title":"Glycine binding primes NMDA receptor internalization","volume":"422","author":"Nong","year":"2003","journal-title":"Nature"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1126\/science.1083970","article-title":"Facilitation of Spinal NMDA Receptor Currents by Spillover of Synaptically Released Glycine","volume":"300","author":"Ahmadi","year":"2003","journal-title":"Science"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.2174\/1568026616666160405113340","article-title":"Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders","volume":"16","author":"Cioffi","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1124\/jpet.108.136267","article-title":"Spinal Antiallodynia Action of Glycine Transporter Inhibitors in Neuropathic Pain Models in Mice","volume":"326","author":"Morita","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1213\/ANE.0000000000000388","article-title":"Relief of Cancer Pain by Glycine Transporter Inhibitors","volume":"119","author":"Motoyama","year":"2014","journal-title":"Anesth. Analg."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Armbruster, A., Neumann, E., K\u00f6tter, V., Hermanns, H., Werdehausen, R., and Eulenburg, V. (2018). The GlyT1 Inhibitor Bitopertin Ameliorates Allodynia and Hyperalgesia in Animal Models of Neuropathic and Inflammatory Pain. Front. Mol. Neurosci., 10.","DOI":"10.3389\/fnmol.2017.00438"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.eururo.2012.01.044","article-title":"Glycine Transporter Type 2 (GlyT2) Inhibitor Ameliorates Bladder Overactivity and Nociceptive Behavior in Rats","volume":"62","author":"Yoshikawa","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1007\/s00213-016-4317-7","article-title":"Effects of the glycine reuptake inhibitors bitopertin and RG7118 on glycine in cerebrospinal fluid: Results of two proofs of mechanism studies in healthy volunteers","volume":"233","author":"Hofmann","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_64","unstructured":"Yoshizawa, T., Okada, H., Yoshikawa, S., Takahashi, S., and Yoshimura, N. (2014, January 20). Suppression of neurogenic detrusor overactivity by glycine transporter type 2(GLYT2) inhibitor in rats with spinal cord injury. Neurophysiology and Bladder Dysfunction Scientific Podium Poster Session 41, International Continence Symposium. Proceedings of the 2014 International Continence Society Meeting, Rio De Janeiro, Brazil. Abstract 644."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuropharm.2017.07.018","article-title":"P2X receptors up-regulate the cell-surface expression of the neuronal glycine transporter GlyT2","volume":"125","author":"Zafra","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/7493286","article-title":"Spinal Cord Glycine Transporter 2 Mediates Bilateral ST35 Acupoints Sensitization in Rats with Knee Osteoarthritis","volume":"2019","author":"Bai","year":"2019","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/00001756-200508010-00019","article-title":"Inhibitors of GlyT1 and GlyT2 differentially modulate inhibitory transmission","volume":"16","author":"Xu","year":"2005","journal-title":"Neuroreport"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1021\/jm0011272","article-title":"The first potent and selective inhibitors of the glycine transporter type 2","volume":"44","author":"Caufiled","year":"2001","journal-title":"J. Med. Chem."},{"key":"ref_69","unstructured":"Morphy, J.R., and Rankovoc, Z. (2004). N-[(1-Dimethylaminocycloalkyl)methyl)benzamide Derivatives. (Application US20040242685A1), U.S. Patent."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jphs.2017.02.011","article-title":"Electrophysiological evidence of increased glycine receptor-mediated phasic and tonic inhibition by blockade of glycine transporters in spinal superficial dorsal horn neurons of adult mice","volume":"133","author":"Oyama","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1113\/jphysiol.2004.068858","article-title":"Role of glial and neuronal glycine transporters in the control of glycinergic and glutamatergic synaptic transmission in lamina X of the rat spinal cord","volume":"559","author":"Bradaia","year":"2004","journal-title":"J. Physiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The Antinociceptive Effect of Intrathecal Administration of Glycine Transporter-2 Inhibitor ALX1393 in a Rat Acute Pain Model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth. Analg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2008.09.012","article-title":"Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain","volume":"445","author":"Hermanns","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1254\/jphs.09351FP","article-title":"Blockade of glycine transporter (GlyT) 2, but not GlyT1, ameliorates dynamic and static mechanical allodynia in mice with herpetic or postherpetic pain","volume":"112","author":"Nishikawa","year":"2010","journal-title":"J. Pharmacol. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0896-6273(03)00673-1","article-title":"Deletion of the Mouse Glycine Transporter 2 Results in a Hyperekplexia Phenotype and Postnatal Lethality","volume":"40","author":"Gomeza","year":"2003","journal-title":"Neuron"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.mcn.2010.04.005","article-title":"Development of synaptic inhibition in glycine transporter 2 deficient mice","volume":"44","author":"Latal","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Bogdanik, L.P., Chapman, H.D., Miers, K.E., Serreze, D.V., and Burgess, R.W. (2012). A MusD retrospoon insertion in the mouse Slc6a5 gene causes alterations in neuromuscular junction maturation and behavioral phenotypes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030217"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2018.03.013","article-title":"Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation","volume":"305","author":"Kamizato","year":"2018","journal-title":"Exp. Neurol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"28975","DOI":"10.1074\/jbc.M112.372094","article-title":"Mutations in the GlyT2 Gene (SLC6A5) Are a Second Major Cause of Startle Disease*","volume":"287","author":"Carta","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1814","article-title":"Mutations in the human GlyT2 gene define a presynaptic component of human startle disease","volume":"38","author":"Rees","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bbrc.2006.07.080","article-title":"Mutations within the human GLYT2 (SLC6A5) gene associated with hyperekplexia","volume":"348","author":"Eulenburg","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Davies, J.S., Chung, S.-K., Thomas, R.H., Robinson, A., Hammond, C.L., Mullins, J.G.L., Carta, E., Pearce, B.R., Harvey, K., and Harvey, R.J. (2010). The glycinergic system in human startle disease: A genetic screening approach. Front. Mol. Neurosci., 3.","DOI":"10.3389\/fnmol.2010.00008"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1476-5381.2010.00935.x","article-title":"N-arachidonyl-glycine modulates synaptic transmission in superficial dorsal horn","volume":"161","author":"Jeong","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.neuint.2013.08.012","article-title":"Lipid inhibitors of high affinity glycine transporters: Identification of a novel class of analgesics","volume":"73","author":"Carland","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1021\/acschemneuro.7b00105","article-title":"Synthesis and Characterization of Novel Acyl-Glycine Inhibitors of GlyT2","volume":"8","author":"Mostyn","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1021\/acs.jmedchem.8b01775","article-title":"Development of an N-Acyl Amino Acid That Selectively Inhibits the Glycine Transporter 2 To Produce Analgesia in a Rat Model of Chronic Pain","volume":"62","author":"Mostyn","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Wilson, B., Alamein, C., Mostyn, S.N., Shimmon, S., Rawling, T., Christie, M., Vandenberg, R.J., and Mohammadi, S. (2020). Peripheral administration of selective GlyT2 inhibitor, oleoyl-d-lysine, is analgesic in a mouse model of neuropathic pain. Authorea, preprint.","DOI":"10.22541\/au.159665030.05958468"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Mostyn, S.N., Wilson, K., Schumann-Gillett, A., Frangos, Z.J., Shimmon, S., Rawling, T., Ryan, R.M., O\u2019Mara, M.L., and Vandenberg, R.J. (2019). Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics. eLife, 8.","DOI":"10.7554\/eLife.47150"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Wilson, K.A., Mostyn, S.N., Frangos, Z.J., Shimmon, S., Rawling, T., Vandenberg, R.J., and O\u2019Mara, M.L. (2021). The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity. J. Biol. Chem., 296.","DOI":"10.1016\/j.jbc.2021.100282"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/bph.12343","article-title":"Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while pre-serving efficacy in the treatment of pain","volume":"170","author":"Ghisdal","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jcph.973","article-title":"Safety, Tolerability, and Pharmacokinetic Characteristics of a Novel Nonopioid Analgesic, VVZ-149 Injections in Healthy Volunteers: A First-in-Class, First-in-Human Study","volume":"58","author":"Oh","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.drudis.2012.01.003","article-title":"Foundation Review: A series of case studies: Practical methodology for identifying antinociceptive multitarget drugs","volume":"17","author":"Pang","year":"2012","journal-title":"Drug Discov. Today"},{"key":"ref_93","unstructured":"Lee, D.H., Ham, M.S., and Lee, J.-H. (2016). Novel Benzamide Derivatives and Use Thereof. (9,359,346 B2), U.S. Patent."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Song, I., Cho, S., Nedeljkovic, S.S., Lee, S.R., Lee, C., Kim, J., and Bai, S.J. (2021). Role of VVZ-149, a Novel Analgesic Molecule, in the Affective Component of Pain: Results from an Exploratory Proof-of-Concept Study of Postoperative Pain following Laparoscopic and Robotic-Laparoscopic Gastrectomy. Pain Med.","DOI":"10.1093\/pm\/pnab066"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jphs.2015.02.010","article-title":"Analgesic effect of GT-0198, a structurally novel glycine transporter 2 inhibitor, in a mouse model of neuropathic pain","volume":"127","author":"Omori","year":"2015","journal-title":"J. Pharmacol. Sci."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1016\/j.bmcl.2014.06.059","article-title":"The discovery of potent glycine transporter type-2 inhibitors: Design and synthesis of phenoxymethylbenzamide derivatives","volume":"24","author":"Takahashi","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s43440-020-00145-8","article-title":"Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain","volume":"72","author":"Imam","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1016\/j.bmc.2004.05.042","article-title":"Novel glycine transporter type-2 reuptake inhibitors. Part 1:\u03b1-amino acid derivatives","volume":"12","author":"Wolin","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1016\/j.bmc.2004.05.043","article-title":"Novel glycine transporter type-2 reuptake inhibitors. Part 2: \u03b2- and \u03b3-amino acid derivatives","volume":"12","author":"Wolin","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmc.2004.05.044","article-title":"Inhibitors of the glycine transporter type-2 (GlyT-2): Synthesis and biological activity of benzoylpiperidine derivatives","volume":"12","author":"Wolin","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bmcl.2003.09.080","article-title":"2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors","volume":"14","author":"Ho","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/acsmedchemlett.9b00003","article-title":"Discovery of GlyT2 Inhibitors Using Structure-Based Pharmacophore Screening and Selectivity Studies by FEP+ Calculations","volume":"10","author":"Fratev","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Mohammadzadeh, A., Lakatos, P., Balogh, M., Z\u00e1dor, F., Kar\u00e1di, D., Z\u00e1dori, Z., Kir\u00e1ly, K., Galambos, A., Barsi, S., and Riba, P. (2021). Pharmacological Evidence on Augmented Antiallodynia Following Systemic Co-Treatment with GlyT-1 and GlyT-2 Inhibitors in Rat Neuropathic Pain Model. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052479"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.brainresbull.2019.07.008","article-title":"Glycine transporter inhibitors: A new avenue for managing neuropathic pain","volume":"152","author":"Mohammadzadeh","year":"2019","journal-title":"Brain Res. Bull."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature04223","article-title":"BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain","volume":"438","author":"Coull","year":"2005","journal-title":"Nature"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.celrep.2019.06.059","article-title":"Chloride Dysregulation through Downregulation of KCC2 Mediates Neuropathic Pain in Both Sexes","volume":"28","author":"Mapplebeck","year":"2019","journal-title":"Cell Rep."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Ferrini, F., Perez-Sanchez, J., Ferland, S., Lorenzo, L.-E., Godin, A.G., Plasencia-Fernandez, I., Cottet, M., Castonguay, A., Wang, F., and Salio, C. (2020). Differential chloride homeostasis in the spinal dorsal horn locally shapes synaptic metaplasticity and modality-specific sensitization. Nat. Commun., 11.","DOI":"10.1038\/s41467-020-17824-y"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/864\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:13:08Z","timestamp":1760163188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/11\/6\/864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,10]]},"references-count":107,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["biom11060864"],"URL":"https:\/\/doi.org\/10.3390\/biom11060864","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,10]]}}}